Why a records review cannot answer every NSCLC question
A pathology report, a biomarker result and a scan disc travel well. They tell a specialist what was found and, to a degree, what has changed. They do not show how you breathe on a flight of stairs, how much weight you have lost, or how a treated lung moves when you cough. Those observations shape what a treating team is willing to offer.
This is the practical reason a China hospital may answer some questions from your file and hold others until you attend. A records-based opinion can clarify the diagnosis, comment on staging information and suggest which specialties should see you. It cannot confirm that you are fit for a particular procedure, that a bed or slot exists, or that a treatment will be given. Suitability is the hospital's decision, made by licensed clinicians who have examined you.
So the useful question is not "can everything be decided remotely?" It is "which of my questions need me in the room, and which can be narrowed beforehand?" That distinction saves a wasted trip and prevents false expectations on both sides.
Questions that depend on seeing and examining you
Several NSCLC decisions turn on findings that only appear during a physical assessment. A clinician listening to your chest, checking your oxygen saturation, reviewing your current medicines and asking how you manage daily activity builds a picture no report contains. If you have had previous lung surgery, the remaining lung's behaviour matters, and that is assessed in person.
Performance status is a common example. Two patients with similar scans can be offered different options because one is mobile and eating while the other is losing ground. That judgement is clinical, not administrative, and it belongs to the treating team.
Questions to put to the hospital before you travel include: Which parts of my case can be reviewed from records, and which require examination? If I attend, which specialties will see me? What will you need to see for yourself before discussing local treatment such as surgery or radiotherapy, or systemic treatment such as chemotherapy, targeted therapy or immunotherapy?
If you have a lung lobectomy in your history, note that a lobectomy removes one lobe of the lung, which is different from removing an entire lung. Ask the team how that history affects their assessment of you now. Do not assume a fixed rule; ask what they need to see.
Pathology, biomarker and imaging questions to settle first
Before an in-person visit is worth arranging, confirm that the receiving team can actually read what you send. Pathology slides and blocks, biomarker reports, and imaging on disc are the core items. Ask whether the hospital wants the original slides for its own pathology review or accepts your existing report. Ask whether it needs the imaging in a specific format.
A frequent gap is a biomarker result reported by a laboratory the receiving team cannot verify. Ask whether a re-review is needed and who arranges it. Another gap is a scan done months ago with no comparison images. Ask whether earlier imaging should be included so the team can see change over time.
These are questions, not instructions. The hospital decides what it requires. What you can do is ask for its written list before sending anything, then confirm what arrived and what is still missing. That avoids a visit built on an incomplete file.
Previous cancer therapy: what the team must verify
If you have already had treatment, the new team needs to know what was given, when, at what dose, and why it stopped. That includes surgery, radiotherapy, chemotherapy, targeted therapy and immunotherapy. A summary letter is useful, but the underlying treatment records carry more weight because they show the actual agents, cycles and dates rather than someone's recollection of them.
The reason this matters for non-small cell lung cancer in China is that prior therapy changes how a new team reads your case. A drug that worked and was stopped for a planned reason tells a different story from one stopped early because of toxicity. The receiving clinicians need the original reason, not a paraphrase, before they can judge what a further local or systemic option would involve for you.
Some of this can be reviewed remotely. What cannot be settled from a file is how you tolerated previous treatment and what your current organ function and blood counts show. Those influence whether a further local or systemic option is realistic, and they change over time. A blood count from three months ago does not describe you now.
Ask the hospital: Which previous treatment records do you need, and in what form? Will you accept a translated summary, or do you need source documents? If my previous therapy was stopped for toxicity, what will you assess before considering anything further? These are the questions that turn a vague enquiry into a specific one.
One practical step: request a treatment chronology from your previous oncology team. Ask them to list each regimen, the start and stop dates, the reason for stopping, and any dose reductions. That single document often answers questions that would otherwise require several rounds of correspondence, and it gives the China team a clear starting point for its own review.
If a record genuinely cannot be obtained, say so rather than leaving a gap unexplained. Ask the hospital what alternative it accepts, such as a letter from the treating oncologist summarising the missing period. Do not assume a missing document ends the discussion; ask what the team can work with and what it still needs.
Local and systemic options: what can be discussed remotely and what cannot
Local options for NSCLC include surgery and radiotherapy; systemic options include chemotherapy, targeted therapy and immunotherapy. Which of these is relevant depends on stage, pathology, biomarkers, your general condition and your own priorities. A records review can map the possibilities. It cannot select one for you.
A remote discussion is a reasonable way to learn whether travelling to China is worth considering at all. It can tell you whether the team sees a question it can help with, and which additional records it wants. It should not be treated as a treatment plan. A plan requires examination, and often a multidisciplinary discussion.
Ask: Based on my records, which options are worth assessing in person? What would make an option unsuitable? If I travel, how many visits should I plan for, and what is confirmed versus provisional? Do not accept a remote answer as a guarantee of treatment, and do not treat a declined remote opinion as a final refusal.
A practical order for your questions and records
Start with a short summary: diagnosis, date, key pathology and biomarker results, treatment so far, current symptoms and your main question. Send that first. Ask the hospital or coordination team what it needs next rather than sending everything at once.
Then confirm three things in writing: which questions the team can address from records, which require an in-person assessment, and what records are still missing. If a step cannot be completed, for example a slide block cannot be shipped, ask what alternative the hospital accepts. If no reply comes, follow up once with a specific question rather than resending the whole file.
A reply confirms that your records were received and reviewed at a preliminary level. It does not confirm hospital acceptance, a treatment decision, a date, or a fee. Those come later and from the hospital.
If you want help with records handling, interpretation or requesting a specialist appointment, ChinaSpecialistCare can assist with that coordination. An initial enquiry is free and does not require buying a proxy consultation. The hospital still decides suitability. You can begin with a brief summary through the enquiry form, and share fuller records after first contact.
For background on the surgical option sometimes discussed in NSCLC, see the lung lobectomy reference.
Sources & scope of this guide
References and official service information relevant to this guide.
This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.